Globalization

India invests to boost domestic API manufacture

26-Mar-2020 By Ben Hargreaves

Following API constraints due to the coronavirus, the Indian government takes measures to bolster domestic capabilities.

The latest action by industry on COVID-19

25-Mar-2020 By Ben Hargreaves

A rundown of the latest updates emerging from industry in response to the developing coronavirus pandemic.

FDA lifts import alert on Ipca Labs for chloroquine supply

24-Mar-2020 By Ben Hargreaves

In order to boost the supply of chloroquine, the US FDA has allowed Ipca to supply APIs and finished product to the country.

Generics manufacturer prioritizes cardiac drugs amid shortages fears

23-Mar-2020 By Vassia Barba

Medivant to prioritize manufacturing of four generic drugs for cardiac diseases, amid fears of drug shortages due to COVID-19.

EMA calls to scale up COVID-19 trials for conclusive data

23-Mar-2020 By Vassia Barba

The agency says the industry should prioritize large randomized controlled studies developing COVID-19 treatments, to acquire robust data.

Trial management service available for free amid COVID-19 pandemic

23-Mar-2020 By Vassia Barba

Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.

Pharma events update: rescheduled, canceled, online

18-Mar-2020 By Jenni Spinner

This list includes the industry events that have been postponed or moved because of the coronavirus pandemic.

FDA and EMA provide timeline updates on action against coronavirus

18-Mar-2020 By Ben Hargreaves

Both the US FDA and EMA are updating timelines of steps taken to prevent the spread of the virus and to secure supply chains.

Sanofi currently ‘does not anticipate’ medicine shortages

17-Mar-2020 By Ben Hargreaves

With the coronavirus impacting the supply of API, Sanofi issues a notice that its global network is secure.

Agilex expands bioanalytical labs capacity to meet US, APAC demand

17-Mar-2020 By Vassia Barba

Agilex has expanded its bioanalytical laboratories by 30%, in order to accommodate demand coming mainly from US and APAC-based biotech companies.

Report sees ‘untold’ coronavirus impact on clinical research

17-Mar-2020 By Vassia Barba

A report by Science 37 examines key considerations for patient safety and business continuity in the clinical trial industry in light of the ongoing coronavirus pandemic.

Pfizer’s five-step coronavirus plan, calls on industry to join forces

16-Mar-2020 By Vassia Barba

Pfizer offers its resources to support research against the coronavirus under a five-point plan, calling for other companies to act accordingly.

US FDA to focus only on ‘mission-critical’ foreign inspections

11-Mar-2020 By Ben Hargreaves

As a result of the coronavirus, the FDA decides to postpone ‘most’ non-US inspections through April, beginning immediately.

EMA says shortages due to coronavirus ‘cannot be excluded’

11-Mar-2020 By Vassia Barba

Evaluating the situation, the EMA has formed an Executive Steering Group to address the impact of the coronavirus outbreak on the supply of medicines.

Indian export group says European industry ‘panicking’ over APIs

05-Mar-2020 By Ben Hargreaves

After the Indian government moved to limit the export of APIs, an Indian export association says fear is spreading amongst European businesses over supply.